全文获取类型
收费全文 | 14968篇 |
免费 | 1358篇 |
国内免费 | 355篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 294篇 |
妇产科学 | 173篇 |
基础医学 | 1018篇 |
口腔科学 | 7篇 |
临床医学 | 1269篇 |
内科学 | 606篇 |
皮肤病学 | 31篇 |
神经病学 | 206篇 |
特种医学 | 228篇 |
外国民族医学 | 11篇 |
外科学 | 7342篇 |
综合类 | 2029篇 |
现状与发展 | 1篇 |
预防医学 | 273篇 |
眼科学 | 6篇 |
药学 | 880篇 |
7篇 | |
中国医学 | 231篇 |
肿瘤学 | 2067篇 |
出版年
2024年 | 60篇 |
2023年 | 223篇 |
2022年 | 454篇 |
2021年 | 571篇 |
2020年 | 575篇 |
2019年 | 539篇 |
2018年 | 538篇 |
2017年 | 563篇 |
2016年 | 478篇 |
2015年 | 599篇 |
2014年 | 1050篇 |
2013年 | 1016篇 |
2012年 | 783篇 |
2011年 | 1019篇 |
2010年 | 856篇 |
2009年 | 788篇 |
2008年 | 712篇 |
2007年 | 703篇 |
2006年 | 749篇 |
2005年 | 637篇 |
2004年 | 557篇 |
2003年 | 511篇 |
2002年 | 435篇 |
2001年 | 369篇 |
2000年 | 252篇 |
1999年 | 198篇 |
1998年 | 183篇 |
1997年 | 146篇 |
1996年 | 117篇 |
1995年 | 97篇 |
1994年 | 125篇 |
1993年 | 71篇 |
1992年 | 73篇 |
1991年 | 59篇 |
1990年 | 73篇 |
1989年 | 52篇 |
1988年 | 55篇 |
1987年 | 58篇 |
1986年 | 37篇 |
1985年 | 46篇 |
1984年 | 46篇 |
1983年 | 36篇 |
1982年 | 34篇 |
1981年 | 19篇 |
1980年 | 25篇 |
1979年 | 24篇 |
1978年 | 27篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1973年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
目的 研究糖尿病膀胱病变(Diabetic cystopathy,DCP)储尿期尿动力学特征及膀胱感觉功能障碍,为阐明DCP的发病机制提供实验依据。方法 分别以链脲佐菌素(STZ)、蔗糖诱导制作大鼠DCP模型及利尿模型,正常大鼠作对照。采用免疫组化结合图像分析技术观察膀胱感觉神经递质CGRP及其纤维改变;制备离体全膀胱,作膀胱灌注测压观察膀胱顺应性改变;放免法测定逼尿肌舒张信号转导分子cAMP。结果 DCP8周时,膀胱壁尤其是粘膜下层的CGRP及其神经纤维明显减少;离体膀胱测压显示糖尿病膀胱顺应性升高;膀胱舒张作用明显弱于对照组和利尿组,逼尿肌cAMP含量显著低于后者。结论 ①DCP对膀胱功能的损害是多方面的:CGRP为主要递质的粘膜下层膀胱容量感觉纤维明显减少,膀胱顺应性改变是DCP的致病机制之一。②DCP早期即已发生储尿期功能障碍,并且可能是膀胱收缩功能损伤的因素。③非糖尿病性利尿状态(多尿)对膀胱功能构成一定的损害作用,但不是DCP形成的主要原因。提示临床上对糖尿病患者作必要的尿动力学检查能较早发现DCP,有助于保护膀胱功能。 相似文献
32.
目的 研究Ⅳ型胶原在膀胱癌中的表达及其临床意义。方法 应用免疫组化方法检测Ⅳ型胶原在65例膀胱癌及19例非肿瘤性膀胱组织中的表达,分析其与膀胱癌的病理分级、分期、复发、多发的关系。结果 Ⅳ型胶原表达与膀胱癌的病理分级、分期相关(P<0.01),而与肿瘤的复发、多发无明显相关(P>0.05),非肿瘤性膀胱组织未见Ⅳ型胶原染色。结论 Ⅳ型胶原的表达与膀胱癌浸润和转移相关,对膀胱癌的预后判断及治疗具有一定的意义。 相似文献
33.
34.
35.
A. J. Pope P. J. R. Shaw M. J. Coptcoat P. H. L. Worth 《Neurourology and urodynamics》1990,9(5):503-508
The changes in bladder function occurring after a surgical alteration in bladder outflow resistance were studied in 20 males undergoing transurethral prostatectomy (TURP) and in 20 females undergoing an endoscopic bladder neck suspension (EBNS). Serial cystometrograms (CMG) were performed before operation, and on alternate days after spontaneous micturition was re-established, for 5 days in the males and for 21 days in the females. CMGs were repeated at 3 months and 1 year after operation. After TURP voiding pressures (Pdet) fell rapidly from a mean of 118 cm H2O before operation to 57 cm H2O at 5 days, with an increase in flow rate during this time from 10.5 ml/s to 24 ml/s. Detrusor instability that had been present in 14 patients resolved within 2 days in 12. There was no further significant urodynamic change over the 1-year study period. After EBNS, there was an early rise in voiding pressure (Pdet rose from 26 cm H2O before operation to 42 cm H2O at 3 days). This continued to increase up to 21 days particularly in those patients with initial large residuals. Three patients developed detrusor instability. Flow rates were greatly reduced at first (27 ml/s before operation and 13 ml/s at 3 days), and gradually increased in line with voiding pressures, yet were still diminished 1 year after operation. The urodynamic changes following a reduction in bladder outflow resistance by TURP are immediate and sustained and unlikely to be the result of structural changes within the bladder wall. EBNS produces an increase in outflow resistance and it can be several weeks before balanced voiding is achieved, with significantly increased detrusor pressures needed to achieve complete bladder emptying at a reduced flow rate. 相似文献
36.
Keiji Ogura Shigeki Fukuzawa Tomonori Habuchi Osamu Ogawa Osamu Yoshida 《International journal of urology》1997,4(6):561-565
Background :
In an attempt to determine the biological significance of nuclear morphometric findings, measurements of mean nuclear volume (MNV) and nuclear roundness factor (NRF) were compared to the immunoreactivityof p53 expression and proliferating cell nuclear antigen (PCNA) in human bladder cancer.
Methods :
MNV and NRF were measured using stereological methods. Expression of p53 and PCNA were determined by immunohistochemical staining. Specimens from 111 patients with previously untreated bladder cancer were analyzed.
Results :
The mean MNV was 235.8 ± 1 33.6 μm3 for the 81 patients with p53-labeling index (LI) less than 10% and 337.2 ± 141.0 μn3 for the 30 patients with p53 LI greater than 10% (P = 0.008). There was Resign if icant correlation between NRF and expression of p53. The mean MNV was 220.1 ± 1 20.5 μm3 for the 67 patients with PCNA LI less than 28% (the mean value of PCNA LI) and 328.9 ± 149.2 μm3 in 44 patients with PCNA LI greater than 28% (P= 0.0001). The mean NRF was 80.7 ± 4.2 for the 67 patients with PCNA LI less than 28%, and 82.3 ± 3.4 for the 44 patients with PCNA LI more than 28% (P= 0.04). Conclusion: Nuclear morphometric findings may reflect the proliferative potential of cancer eel Is of the bladder, as indicated by findings of immunostaining for p53 and PCNA. 相似文献
In an attempt to determine the biological significance of nuclear morphometric findings, measurements of mean nuclear volume (MNV) and nuclear roundness factor (NRF) were compared to the immunoreactivityof p53 expression and proliferating cell nuclear antigen (PCNA) in human bladder cancer.
Methods :
MNV and NRF were measured using stereological methods. Expression of p53 and PCNA were determined by immunohistochemical staining. Specimens from 111 patients with previously untreated bladder cancer were analyzed.
Results :
The mean MNV was 235.8 ± 1 33.6 μm
37.
膀胱肿瘤组织中端粒酶催化亚基和c-myc的表达 总被引:1,自引:0,他引:1
目的 研究膀胱肿瘤组织中端粒酶催化亚基(hTERT)和c-myc间的表达及关系。方法 采用逆转录-聚合酶链反应(RT-PCR)法对27例膀胱肿瘤组织、16例癌旁组织和16例正常膀胱粘膜同时测定hTERT和c-myc表达,分析两指标在3种组织的表达差异和相关性。结果 TCC组织hTERT和c-myc的表达阳性率分别为100.0%(27/27)和66.7%(18/27);癌旁组织两指标的阳性率均为 37.5%,而正常膀胱粘膜分别为 0和 25.0%;hTERT和c-myc两指标在膀胱肿瘤组织中的阳性表达有相关性(P<0.01)。结论 hTERT较c-myc作为TCC的诊断指标更灵敏和特异;两指标在TCC中的阳性表达具有相关性。 相似文献
38.
目的 通过临床应用膀胱腔内灌注抗人膀胱癌免疫毒素 (BDI- 1-MT) ,观察治疗膀胱癌和预防膀胱癌术后复发的效果及毒副反应。方法 对 18例术后和 5例未手术的膀胱癌病人 ,膀胱腔内灌注BDI- 1-MT 1个疗程以上 ,观察疗效、复发情况及毒副反应。结果 术后 18例随访 6~ 2 0个月未见复发 ,未手术 5例随访 6~ 2 1个月 ,其中 3例显效 ,2例有效。所有病例均无明显毒副反应。结论 膀胱腔内灌注BDI- 1-MT治疗膀胱癌和预防膀胱癌术后复发有良好效果 ,是一种值得推广的新方法。 相似文献
39.
目的:探讨膀胱癌中凝集素受体分布与其分化程度和浸润深度的关系。方法:应用生物素标记的花生凝集素(PNA)、麦胚凝集素(WGA)及刀豆凝集素(ConA)等3种凝集素对52例人体膀胱癌、10例正常人体膀胱粘膜,进行亲合组织化学法研究。结果:发现正常膀胱粘膜PNA、WGA受体阴性,PNA受体阳性率随膀胱癌病理分级的上升而递增,差异具有显著性意义(P<0.05)。PNA、WGA受体阳性率在浸润性肿瘤中明显高于浅表性肿瘤(P<0.05)。结论:提示PNA、WGA受体阳性率与膀胱癌分化程度和浸润深度有关。 相似文献
40.
Aman SHARMA Susheel KUMAR Ajay WANCHU A. K. MANDAL Surjit SINGH Pradeep BAMBERY 《International journal of rheumatic diseases》2007,10(2):153-155
Inflammatory myopathies like dermatomyositis are associated with increased incidence of malignancies. This association has been commonly reported with malignancies of ovaries, gastro‐intestinal tract, breast and non‐Hodgkin's lymphomas but occurrence of dermatomyositis with bladder cancer has been rarely reported. We report a patient with carcinoma bladder who developed dermatomyositis while being treated for the bladder cancer. 相似文献